Lung Cancer Clinical Trial
Official title:
The Effect of Direct Referral for Fast CT Scan in Early Lung Cancer Detection in General Practice. Clinical, Randomised Trial
Background: The primary investigation of lung cancer (LC) is for 85% of the cases conducted
through General Practice, sadly it tends to take a relatively long time from first time the
patient is seen by their General Practitioner and until they are diagnosed. LC symptoms are
common, but usual because of benign diseases. Only 33% of LC patients presenting with alarm
symptoms. On average a General Practitioner in Denmark sees only one patient with newly
diagnosed lung cancer a year and the doctor will therefore get the clinical experience that
when they refer a patient, test often come out negative and they therefore fail to refer and
delay will increase - with a poorer prognosis as a result. Centrally in the diagnosis is
conventional chest X-ray, which unfortunately is inefficient in many cases, while CT
scanning has proven effective even for small tumors.
Hypothesis and aims: The project has three main hypotheses to be tested 1) the GP's use of
cancer fast-track and detection of suspected lung cancer can be optimized in relation to
interpretation of symptoms and subsequent referral practices and radiological investigation.
2) General Practitioners with special training can change the referral routines and 3)
direct access to fast CT scanning leads to earlier diagnosis of lung cancer.
Methods: The first part of the study is a register-based study of lung cancer patients' road
to diagnosis, based on a database of newly diagnosed cancer patients in a year. Second part
of the study is a clinical, randomized study of the effect of referral directly to fast
chest CT scan. Primary endpoint is delay, secondary endpoints are referral pattern (use of
fast-track packet), primary use of CT and 1-year mortality. Furthermore side effects,
including patient groups with increased delay.
The study will contribute new knowledge to the way GP's interpret symptoms, the way they
refer their patients when they suspect cancer, their use of diagnostic imaging and cancer
fast-track pathways. It will then provide a unique opportunity to create the necessary
knowledge about the effects of direct referral to fast CT scan and it might be a decision
aid whether to open for direct CT scan in General Practice for a group of patients.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
| Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
| Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
| Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
| Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
| Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
| Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
| Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
| Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
| Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|